The article titled, “Nek6 Mediates Human Cancer Cell Transformation and Is a Potential Cancer Therapeutic Target,” which was published in the May 2010 issue of Molecular Cancer Research (1), is being retracted at the request of Pfizer.

The AACR Publications Department recently received a letter from a Pfizer representative reporting the results of an investigation of image duplication in Figs. 3A, 3D, 4A, and 5A that were also noted several months ago on the PubPeer.com website. The investigation found that all of the images in question appear to be duplications and most of the authentic, original images that should have been used in place of the duplicated images cannot be located. To ensure that the research record is correct, Pfizer is requesting Retraction of the article and has obtained consent from six authors. All authors have consented to this Retraction except for Lihua Shao who could not be located.

1.
Nassirpour
R
,
Shao
L
,
Flanagan
P
,
Abrams
T
,
Jallal
B
,
Smeal
T
, et al
Nek6 mediates human cancer cell transformation and is a potential cancer therapeutic target
.
Mol Cancer Res
2010
;
8
:
717
28
.